Comprehensive Care for Crohn’s Disease and Ulcerative Colitis
IBD management requires a multidisciplinary approach combining medication therapy, nutritional support, and regular monitoring to achieve and maintain remission while optimising quality of life.
Treatment Philosophy
Our approach emphasises early, effective treatment to prevent complications and achieve mucosal healing. We utilise the latest evidence-based protocols while tailoring therapy to individual patient needs and disease patterns.
Medication Management
5-Aminosalicylates: First-line therapy for mild to moderate ulcerative colitis, with various formulations available for targeted delivery.
Corticosteroids: For acute flares, with emphasis on appropriate tapering and steroid-sparing strategies.
Immunomodulators: Azathioprine, mercaptopurine, and methotrexate for maintenance therapy and steroid-sparing effects.
Biologic Therapies: Anti-TNF agents, integrin antagonists, and interleukin inhibitors for moderate to severe disease. Careful patient selection and monitoring optimise outcomes.
JAK Inhibitors: Newer oral therapies offering additional options for refractory cases.
Monitoring and Assessment
Regular clinical assessment combined with objective measures including inflammatory markers, faecal calprotectin, and endoscopic evaluation ensures optimal disease control and early detection of complications.
Nutritional Support
IBD often affects nutritional status. We provide comprehensive nutritional assessment and support, including vitamin supplementation, dietary counselling, and management of malabsorption.
Long-term Care
IBD requires lifelong management with regular monitoring for disease activity, treatment response, and potential complications. Our comprehensive approach includes cancer surveillance and bone health assessment.
